Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.86−0.01 (-0.15%)
Close on Nov 19, 2026Market cap $621.27MP/E –Yield –
Verastem shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Verastem's shares outstanding was 100M at Jun 30, 2026. For fiscal 2025 it was 69M, up 94.1% from the year before. Over ten years it grew 36.9% a year on average. The highest annual figure on record is 69M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69M | +94.1% |
| FY2024 | Dec 31, 2024 | 36M | +61.9% |
| FY2023 | Dec 31, 2023 | 22M | +36.7% |
| FY2022 | Dec 31, 2022 | 16M | +11.0% |
| FY2021 | Dec 31, 2021 | 15M | +113650.2% |
| FY2020 | Dec 31, 2020 | 0M | -99.8% |
| FY2019 | Dec 31, 2019 | 6M | +7.6% |
| FY2018 | Dec 31, 2018 | 6M | +80.4% |
| FY2017 | Dec 31, 2017 | 3M | +3.9% |
| FY2016 | Dec 31, 2016 | 3M | +2.9% |
| FY2015 | Dec 31, 2015 | 3M | +39.2% |
| FY2014 | Dec 31, 2014 | 2M | +13.8% |
| FY2013 | Dec 31, 2013 | 2M | +20.9% |
| FY2012 | Dec 31, 2012 | 2M | +1349.0% |
| FY2011 | Dec 31, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 100M | +35.2% |
| Q1 FY2026 | Mar 31, 2026 | 99M | +83.0% |
| Q4 FY2025 | Dec 31, 2025 | 84M | +71.2% |
| Q3 FY2025 | Sep 30, 2025 | 73M | +172.5% |
| Q2 FY2025 | Jun 30, 2025 | 74M | +175.6% |
| Q1 FY2025 | Mar 31, 2025 | 54M | +102.2% |
| Q4 FY2024 | Dec 31, 2024 | 49M | +175.2% |
| Q1 FY2024 | Jun 30, 2024 | 27M | -86.6% |
| Q4 FY2023 | Dec 31, 2023 | 27M | +57.5% |
| Q3 FY2023 | Sep 30, 2023 | 27M | +63.1% |
| Q2 FY2023 | Jun 30, 2023 | 18M | +14.1% |
| Q1 FY2023 | Mar 31, 2023 | 201M | +7.7% |
| Q4 FY2022 | Dec 31, 2022 | 17M | +17.5% |
| Q3 FY2022 | Sep 30, 2022 | 16M | +9.6% |
| Q2 FY2022 | Jun 30, 2022 | 16M | +8.4% |
| Q1 FY2022 | Mar 31, 2022 | 186M | +1202.7% |
| Q4 FY2021 | Dec 31, 2021 | 15M | +2.5% |
| Q3 FY2021 | Sep 30, 2021 | 15M | +6.0% |
| Q2 FY2021 | Jun 30, 2021 | 14M | +4.0% |
| Q1 FY2021 | Mar 31, 2021 | 14M | +58.7% |
| Q4 FY2020 | Dec 31, 2020 | 14M | +122.6% |
| Q3 FY2020 | Sep 30, 2020 | 14M | +128.7% |
| Q2 FY2020 | Jun 30, 2020 | 14M | +123.9% |
| Q1 FY2020 | Mar 31, 2020 | 9M | +46.4% |
| Q4 FY2019 | Dec 31, 2019 | 6M | -16.2% |
| Q3 FY2019 | Sep 30, 2019 | 6M | +0.8% |
| Q2 FY2019 | Jun 30, 2019 | 6M | +20.6% |
| Q1 FY2019 | Mar 31, 2019 | 6M | +45.3% |
| Q4 FY2018 | Dec 31, 2018 | 8M | +116.7% |
| Q3 FY2018 | Sep 30, 2018 | 6M | +95.7% |
| Q2 FY2018 | Jun 30, 2018 | 5M | +65.6% |
| Q1 FY2018 | Mar 31, 2018 | 4M | +37.4% |
| Q4 FY2017 | Dec 31, 2017 | 4M | +13.6% |
| Q3 FY2017 | Sep 30, 2017 | 3M | +1.7% |
| Q2 FY2017 | Jun 30, 2017 | 3M | 0.0% |
| Q1 FY2017 | Mar 31, 2017 | 3M | – |
| Q4 FY2016 | Dec 31, 2016 | 3M | – |
| Q3 FY2016 | Sep 30, 2016 | 3M | – |
| Q2 FY2016 | Jun 30, 2016 | 3M | – |
See a number that looks wrong?